AdolescentsHeadache Disorders (Cluster & Migraine)SchizophreniaNeurological InjuryChronic PainLSD

Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire

This questionnaire-based study (n=2455) found that the risk of Hallucinogen Persisting Perception Disorder (HPPD) may increase with greater past exposure to specific hallucinogens, symptoms were rarely (4.2%) perceived as distressing/impairing.

Authors

  • Earth Erowid
  • Fire Erowid

Published

Drug and Alcohol Dependence
individual Study

Abstract

Despite longstanding reports of prolonged or reoccurring perceptual changes in a subset of hallucinogen users, very little is known about Hallucinogen Persisting Perception Disorder and related visual abnormalities in hallucinogen users. We used an online questionnaire to document the symptoms and relationship to drug use of unusual visual phenomena in hallucinogen users. 16,192 individuals viewed the information sheet and 2679 were included in the study. Of these, 224 reported having unrelated diagnoses associated with unusual visual experiences and were excluded from main analyses. Most (60.6%) of the remaining 2455 participants reported having experienced drug-free visual experiences that resembled hallucinogen effects. Probability of experiencing constant or near-constant symptoms was predicted by greater past exposure to specific hallucinogens, including lysergic acid diethylamide (LSD). Although symptoms were common, few (104, or 4.2% of the sample) found them distressing or impairing enough to consider seeking treatment. Visual changes in hallucinogen users may be more common than previously suspected and are worthy of further study.

Available with Blossom Pro

Research Summary of 'Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire'

Introduction

Hallucinogen use is common, especially among young adults, and a minority of users report prolonged or recurring perceptual changes. The DSM-IV-TR recognises a syndrome termed Hallucinogen Persisting Perception Disorder (HPPD), but the literature on its prevalence, phenomenology, and risk factors is limited and sometimes conflicting. Prior reports emphasise visual disturbances—geometric imagery, motion-perception abnormalities, halos, afterimages, and colour flashes—but many studies are case series or small samples, and some apparent cases may overlap with other conditions such as psychosis, migraine aura, seizures, or stroke. Whether persisting visual changes represent a rare complication of specific drugs (notably LSD) or a more widespread, drug-triggered vulnerability remains uncertain. Baggott and colleagues therefore conducted an exploratory web-based questionnaire study to document the frequency and characteristics of drug-free visual phenomena among people with histories of hallucinogen use, and to examine relationships between these experiences and past exposure to specific psychoactive substances. The investigators chose an online approach to access a large, difficult-to-reach population and to gather initial descriptive data that might guide more objective follow-up research.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (2)

Papers cited by this study that are also in Blossom

Hallucinogen persisting perception disorder: what do we know after 50 years?

Halpern, J. H., Pope Jr, H. G. · Drug and Alcohol Dependence (2003)

204 cited
Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features

Gelkopf, M., Skladman, I., Rudinski, D. et al. · International Clinical Psychopharmacology (2003)

Cited By (23)

Papers in Blossom that reference this study

Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial

Meikle, S., Carter, O., Liknaitzky, P. et al. · Therapeutic Advances in Psychopharmacology (2025)

Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis

Hinkle, J. T., Graziosi, M., Nayak, S. et al. · JAMA Psychiatry (2024)

84 cited
An Integrated theory of false insights and beliefs under psychedelics

McGovern, H., Grimmer, H. J., Doss, M. K. et al. · Communications Psychology (2024)

Extended difficulties following the use of psychedelic drugs: A mixed methods study

Evans, J., Robinson, O., Ketzitzidou-Argyri, E. et al. · PLOS ONE (2023)

123 cited
Psychedelic use and psychiatric risks

Simonsson, O., Goldberg, S. B., Chambers, R. et al. · Psychopharmacology (2023)

Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature

Van Der Walt, A., Ford, H., Fraser, C. L. et al. · Frontiers in Neurology (2022)

Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention and treatment

Doyle, M. A., Ling, S., Lui, L. M. W. et al. · Expert Opinion on Drug Safety (2022)

Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms

Kopra, E., Ferris, J. A., Winstock, A. R. et al. · Journal of Psychopharmacology (2022)

Show all 23 papers
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

Richards, W. A., Garcia-Romeu, A. · International Review of Psychiatry (2018)

Positive psychology in the investigation of psychedelics and entactogens: A critical review

Jungaberle, H., Thal, S., Zeuch, A. et al. · Neuropharmacology (2018)

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives

Martinotti, G., Santacroce, R., Pettorruso, M. et al. · Brain Sciences (2018)

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R. et al. · Trends in Pharmacological Sciences (2017)

Modern clinical research on LSD

Liechti, M. E. · Neuropsychopharmacology (2017)

Phenomenology, Structure, and Dynamic of Psychedelic States

Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences

Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S. et al. · Journal of Psychopharmacology (2016)

Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., Addy, P. H. · Experimental and Clinical Psychopharmacology (2016)

174 cited
New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca

McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations

Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases

Litjens, R. P. W., Brunt, T. M., Alderliefste, G. et al. · European Neuropsychopharmacology (2014)

Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin

MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)

350 cited
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects

Maclean, K. A., Johnson, M. W., Reissig, C. J. et al. · Psychopharmacology (2012)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Abnormal visual experiences in individuals with... — Research Summary & Context | Blossom